Quest PharmaTech Inc.
QPT.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -42.08% | 26.48% | 6.90% | 26.74% | 46.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.65% | -25.26% | -32.39% | 34.85% | 53.31% |
| Operating Income | 39.65% | 25.26% | 32.39% | -34.85% | -53.31% |
| Income Before Tax | 42.87% | 96.70% | 95.47% | 94.12% | 95.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.87% | 96.70% | 95.47% | 94.12% | 95.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.87% | 96.70% | 95.47% | 94.12% | 95.37% |
| EBIT | 39.65% | 25.26% | 32.39% | -34.85% | -53.31% |
| EBITDA | 39.74% | 25.24% | 32.31% | -35.16% | -55.55% |
| EPS Basic | 43.61% | 96.72% | 95.49% | 94.15% | 95.38% |
| Normalized Basic EPS | 23.40% | 17.39% | 11.86% | 8.33% | 53.00% |
| EPS Diluted | 43.61% | 96.72% | 95.49% | 94.15% | 95.39% |
| Normalized Diluted EPS | 23.40% | 17.39% | 11.86% | 8.33% | 53.00% |
| Average Basic Shares Outstanding | 0.00% | 0.27% | 0.29% | 0.32% | 0.43% |
| Average Diluted Shares Outstanding | 0.00% | 0.27% | 0.29% | 0.32% | 0.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |